GE HealthCare Technologies Inc. (GEHC)
NASDAQ • Healthcare
Last close at October 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, GE HealthCare Technologies Inc. keeps $11 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 28
in 18 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
GE HealthCare Technologies beat expectations on both revenue and adjusted EPS in the second fiscal quarter of 2026, reported July 29, 2026, as revenue rose 5.8% to about $5.3 billion and adjusted EPS came in at $1.13 versus the $1.04 estimate, about +9%. Net income increased 17.9% to roughly $573 million from $486 million a year ago, while gross margin held near 41% and operating margin was about 14% on gross profit of about $2.2 billion and operating income of about $739 million. Operating cash flow was negative $517 million, the company repurchased $200 million of stock and paid $16 million in dividends. Consensus for the next period calls for EPS of $1.21 on revenue of $5.35 billion.
Next report — what to expect
GE HealthCare Technologies Inc. (GEHC) reports next on November 4, 2026. Wall Street’s next-period consensus calls for EPS of $1.20 on revenue of $5.35 billion. For trailing context, revenue was +5.8% year over year last quarter. GEHC has beaten EPS in 7 of 8 most recent quarters.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. creates, manufactures, and markets healthcare technology, with shares listed as GEHC on NASDAQ and FY2025 revenue of $20.6 billion. The company sells medical devices, services, and integrated digital solutions that support diagnosis, treatment, and ongoing patient monitoring across imaging, ultrasound, patient care, and diagnostic pharmaceuticals.
Today's Snapshot
The day ended with GEHC 2.4% higher at 65.74, in line with a firmer sector. GE HealthCare is expanding its pharmaceutical diagnostics business.
Trading Volume
Below 10d avg (3.6M)
2.8M
vs S&P 500 Today
Outperforming Market
+1.78%
Updated: October 9, 2026 at 20:23 UTC
GEHC Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$65.15 - $71.16Sell
- RSI (14)48.20Neutral
- Stochastic %K (14, 3, 3)40.89Neutral
- MACD Level (12, 26)-0.81Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.